nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—DRD4—Gilles de la Tourette syndrome	0.221	0.269	CbGaD
Amoxapine—DRD3—Gilles de la Tourette syndrome	0.191	0.232	CbGaD
Amoxapine—SLC6A3—Gilles de la Tourette syndrome	0.177	0.216	CbGaD
Amoxapine—DRD2—Gilles de la Tourette syndrome	0.132	0.16	CbGaD
Amoxapine—HTR2A—Gilles de la Tourette syndrome	0.102	0.124	CbGaD
Amoxapine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00407	0.0773	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00393	0.0745	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00245	0.0465	CbGeAlD
Amoxapine—DRD4—brain—Gilles de la Tourette syndrome	0.00121	0.0229	CbGeAlD
Amoxapine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00111	0.0211	CbGeAlD
Amoxapine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00107	0.0203	CbGeAlD
Amoxapine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00107	0.0203	CbGeAlD
Amoxapine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00103	0.0195	CbGeAlD
Amoxapine—DRD1—midbrain—Gilles de la Tourette syndrome	0.000967	0.0183	CbGeAlD
Amoxapine—DRD3—brain—Gilles de la Tourette syndrome	0.000848	0.0161	CbGeAlD
Amoxapine—HTR6—brain—Gilles de la Tourette syndrome	0.000817	0.0155	CbGeAlD
Amoxapine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000795	0.0151	CbGeAlD
Amoxapine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000783	0.0149	CbGeAlD
Amoxapine—GABRA1—midbrain—Gilles de la Tourette syndrome	0.000783	0.0149	CbGeAlD
Amoxapine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.000777	0.0147	CbGeAlD
Amoxapine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000768	0.0146	CbGeAlD
Amoxapine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000765	0.0145	CbGeAlD
Amoxapine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000751	0.0143	CbGeAlD
Amoxapine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000739	0.014	CbGeAlD
Amoxapine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000712	0.0135	CbGeAlD
Amoxapine—Asenapine—DRD4—Gilles de la Tourette syndrome	0.000704	0.11	CrCbGaD
Amoxapine—ORM1—nervous system—Gilles de la Tourette syndrome	0.000687	0.013	CbGeAlD
Amoxapine—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000661	0.0126	CbGeAlD
Amoxapine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000644	0.0122	CbGeAlD
Amoxapine—GABRA1—nervous system—Gilles de la Tourette syndrome	0.000644	0.0122	CbGeAlD
Amoxapine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000639	0.0121	CbGeAlD
Amoxapine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000632	0.012	CbGeAlD
Amoxapine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00062	0.0118	CbGeAlD
Amoxapine—GABRA1—central nervous system—Gilles de la Tourette syndrome	0.00062	0.0118	CbGeAlD
Amoxapine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000617	0.0117	CbGeAlD
Amoxapine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000615	0.0117	CbGeAlD
Amoxapine—DRD1—brain—Gilles de la Tourette syndrome	0.000608	0.0115	CbGeAlD
Amoxapine—Asenapine—DRD3—Gilles de la Tourette syndrome	0.000607	0.0953	CrCbGaD
Amoxapine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000604	0.0115	CbGeAlD
Amoxapine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000594	0.0113	CbGeAlD
Amoxapine—HTR3A—brain—Gilles de la Tourette syndrome	0.000587	0.0111	CbGeAlD
Amoxapine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000585	0.0111	CbGeAlD
Amoxapine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000583	0.0111	CbGeAlD
Amoxapine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.00058	0.011	CbGeAlD
Amoxapine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000571	0.0108	CbGeAlD
Amoxapine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000564	0.0107	CbGeAlD
Amoxapine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000561	0.0107	CbGeAlD
Amoxapine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000558	0.0106	CbGeAlD
Amoxapine—Mazindol—SLC6A3—Gilles de la Tourette syndrome	0.000542	0.085	CrCbGaD
Amoxapine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00052	0.00986	CbGeAlD
Amoxapine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000515	0.00978	CbGeAlD
Amoxapine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.0005	0.00949	CbGeAlD
Amoxapine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000497	0.00943	CbGeAlD
Amoxapine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000496	0.00941	CbGeAlD
Amoxapine—HTR1B—brain—Gilles de la Tourette syndrome	0.000492	0.00934	CbGeAlD
Amoxapine—GABRA1—brain—Gilles de la Tourette syndrome	0.000492	0.00934	CbGeAlD
Amoxapine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000488	0.00926	CbGeAlD
Amoxapine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000479	0.00909	CbGeAlD
Amoxapine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000478	0.00907	CbGeAlD
Amoxapine—HTR2C—brain—Gilles de la Tourette syndrome	0.000472	0.00896	CbGeAlD
Amoxapine—DRD2—nervous system—Gilles de la Tourette syndrome	0.00047	0.00891	CbGeAlD
Amoxapine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000461	0.00875	CbGeAlD
Amoxapine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000452	0.00858	CbGeAlD
Amoxapine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000447	0.00849	CbGeAlD
Amoxapine—CHRM1—brain—Gilles de la Tourette syndrome	0.000446	0.00846	CbGeAlD
Amoxapine—HTR2B—brain—Gilles de la Tourette syndrome	0.000443	0.00841	CbGeAlD
Amoxapine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000443	0.00841	CbGeAlD
Amoxapine—Asenapine—DRD2—Gilles de la Tourette syndrome	0.00042	0.0659	CrCbGaD
Amoxapine—HTR1A—brain—Gilles de la Tourette syndrome	0.000397	0.00754	CbGeAlD
Amoxapine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000394	0.00747	CbGeAlD
Amoxapine—Olanzapine—DRD4—Gilles de la Tourette syndrome	0.000392	0.0615	CrCbGaD
Amoxapine—HTR7—brain—Gilles de la Tourette syndrome	0.00038	0.0072	CbGeAlD
Amoxapine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000377	0.00715	CbGeAlD
Amoxapine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000371	0.00704	CbGeAlD
Amoxapine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000366	0.00695	CbGeAlD
Amoxapine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000364	0.00691	CbGeAlD
Amoxapine—DRD2—brain—Gilles de la Tourette syndrome	0.000359	0.00681	CbGeAlD
Amoxapine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000357	0.00678	CbGeAlD
Amoxapine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000351	0.00665	CbGeAlD
Amoxapine—Olanzapine—DRD3—Gilles de la Tourette syndrome	0.000338	0.053	CrCbGaD
Amoxapine—Asenapine—HTR2A—Gilles de la Tourette syndrome	0.000325	0.0509	CrCbGaD
Amoxapine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.00031	0.00588	CbGeAlD
Amoxapine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000298	0.00566	CbGeAlD
Amoxapine—HRH1—brain—Gilles de la Tourette syndrome	0.000283	0.00538	CbGeAlD
Amoxapine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000282	0.00535	CbGeAlD
Amoxapine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000278	0.00528	CbGeAlD
Amoxapine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000272	0.00515	CbGeAlD
Amoxapine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000245	0.0385	CrCbGaD
Amoxapine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000243	0.0382	CrCbGaD
Amoxapine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.000238	0.0373	CrCbGaD
Amoxapine—HTR2A—brain—Gilles de la Tourette syndrome	0.000237	0.00449	CbGeAlD
Amoxapine—Olanzapine—DRD2—Gilles de la Tourette syndrome	0.000234	0.0367	CrCbGaD
Amoxapine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000216	0.00409	CbGeAlD
Amoxapine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.00021	0.0329	CrCbGaD
Amoxapine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000205	0.0322	CrCbGaD
Amoxapine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000204	0.0321	CrCbGaD
Amoxapine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000195	0.0307	CrCbGaD
Amoxapine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.00019	0.0298	CrCbGaD
Amoxapine—Olanzapine—HTR2A—Gilles de la Tourette syndrome	0.000181	0.0283	CrCbGaD
Amoxapine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000176	0.0277	CrCbGaD
Amoxapine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000145	0.0228	CrCbGaD
Amoxapine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.000142	0.0223	CrCbGaD
Amoxapine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000122	0.0191	CrCbGaD
Amoxapine—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.000112	0.0176	CrCbGaD
Amoxapine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.00011	0.0172	CrCbGaD
Amoxapine—Clozapine—HTR2A—Gilles de la Tourette syndrome	9.43e-05	0.0148	CrCbGaD
Amoxapine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	6.29e-05	0.000533	CbGpPWpGaD
Amoxapine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	6.27e-05	0.000532	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.27e-05	0.000531	CbGpPWpGaD
Amoxapine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.25e-05	0.000529	CbGpPWpGaD
Amoxapine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	6.18e-05	0.000523	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.13e-05	0.000519	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.11e-05	0.000518	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.03e-05	0.000511	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	6e-05	0.000508	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.96e-05	0.000505	CbGpPWpGaD
Amoxapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.96e-05	0.000505	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.95e-05	0.000504	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.93e-05	0.000503	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.84e-05	0.000495	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	5.83e-05	0.000494	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.81e-05	0.000493	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.78e-05	0.00049	CbGpPWpGaD
Amoxapine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.64e-05	0.000478	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.64e-05	0.000478	CbGpPWpGaD
Amoxapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	5.63e-05	0.000477	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000477	CbGpPWpGaD
Amoxapine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000476	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.62e-05	0.000476	CbGpPWpGaD
Amoxapine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	5.61e-05	0.000476	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.55e-05	0.00047	CbGpPWpGaD
Amoxapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	5.52e-05	0.000468	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.43e-05	0.00046	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.26e-05	0.000446	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.23e-05	0.000443	CbGpPWpGaD
Amoxapine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	5.11e-05	0.000433	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.1e-05	0.000433	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.02e-05	0.000426	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.01e-05	0.000425	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5e-05	0.000423	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000422	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000421	CbGpPWpGaD
Amoxapine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.00042	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.96e-05	0.00042	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.92e-05	0.000417	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.88e-05	0.000413	CbGpPWpGaD
Amoxapine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.87e-05	0.000412	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.87e-05	0.000412	CbGpPWpGaD
Amoxapine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.85e-05	0.000411	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.85e-05	0.000411	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.84e-05	0.00041	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.83e-05	0.00041	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.81e-05	0.000408	CbGpPWpGaD
Amoxapine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.77e-05	0.000405	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.77e-05	0.000405	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.76e-05	0.000403	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.73e-05	0.000401	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.000387	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.54e-05	0.000385	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.54e-05	0.000385	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.53e-05	0.000384	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.52e-05	0.000383	CbGpPWpGaD
Amoxapine—GABRA1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.49e-05	0.00038	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.45e-05	0.000377	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.44e-05	0.000376	CbGpPWpGaD
Amoxapine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000376	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000376	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.43e-05	0.000376	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.38e-05	0.000371	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.31e-05	0.000365	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.31e-05	0.000365	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.3e-05	0.000365	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.29e-05	0.000364	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000363	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.25e-05	0.00036	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.24e-05	0.00036	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.23e-05	0.000358	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.19e-05	0.000355	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.17e-05	0.000353	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.16e-05	0.000352	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.00035	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.09e-05	0.000347	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.05e-05	0.000343	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.000342	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.000341	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.01e-05	0.00034	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.01e-05	0.00034	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4e-05	0.000339	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.93e-05	0.000333	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.92e-05	0.000332	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.91e-05	0.000332	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.91e-05	0.000331	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.9e-05	0.000331	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.89e-05	0.000329	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.85e-05	0.000327	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.000325	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.82e-05	0.000324	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.8e-05	0.000322	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.8e-05	0.000322	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.71e-05	0.000314	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.68e-05	0.000312	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000312	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.66e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.66e-05	0.00031	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.66e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.65e-05	0.000309	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.64e-05	0.000309	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.62e-05	0.000307	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000303	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.54e-05	0.0003	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.49e-05	0.000295	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.47e-05	0.000294	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.46e-05	0.000293	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.41e-05	0.000289	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.37e-05	0.000285	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.000282	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.32e-05	0.000282	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.29e-05	0.000278	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.27e-05	0.000277	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.23e-05	0.000274	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.19e-05	0.00027	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.17e-05	0.000269	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.17e-05	0.000269	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.16e-05	0.000268	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.14e-05	0.000266	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.000264	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.1e-05	0.000262	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.98e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000252	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.97e-05	0.000252	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.96e-05	0.00025	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.9e-05	0.000245	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.89e-05	0.000245	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.000244	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.88e-05	0.000244	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.86e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.84e-05	0.000241	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.00024	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.82e-05	0.000239	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000238	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000238	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000237	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.78e-05	0.000236	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.76e-05	0.000233	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000233	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.74e-05	0.000232	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.73e-05	0.000231	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.7e-05	0.000229	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.7e-05	0.000229	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000228	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.68e-05	0.000227	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.62e-05	0.000222	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.58e-05	0.000219	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.58e-05	0.000218	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000218	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.57e-05	0.000218	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.57e-05	0.000217	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.56e-05	0.000217	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000217	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.55e-05	0.000216	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000216	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000216	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.54e-05	0.000215	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000215	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.52e-05	0.000214	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.51e-05	0.000213	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.51e-05	0.000212	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.5e-05	0.000212	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.5e-05	0.000212	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.49e-05	0.000211	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.00021	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.45e-05	0.000208	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.44e-05	0.000207	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000205	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.39e-05	0.000202	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000202	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000202	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000199	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.34e-05	0.000198	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.33e-05	0.000198	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000197	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.33e-05	0.000197	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.32e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.31e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000196	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.28e-05	0.000193	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.28e-05	0.000193	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.25e-05	0.00019	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.2e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.17e-05	0.000184	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000182	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000182	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.12e-05	0.00018	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.11e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.09e-05	0.000177	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000175	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.97e-05	0.000167	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.96e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000159	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.83e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000155	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000152	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000152	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.000149	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.75e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.71e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.7e-05	0.000144	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000141	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000139	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.000138	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000138	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.59e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.59e-05	0.000134	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.55e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.52e-05	0.000129	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.52e-05	0.000129	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.51e-05	0.000128	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000128	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000128	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.49e-05	0.000126	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.48e-05	0.000125	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.48e-05	0.000125	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.47e-05	0.000125	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.47e-05	0.000124	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.45e-05	0.000123	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.44e-05	0.000122	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.39e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.38e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.38e-05	0.000117	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.37e-05	0.000116	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.37e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.35e-05	0.000114	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.34e-05	0.000114	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.3e-05	0.00011	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.28e-05	0.000109	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.25e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.12e-05	9.46e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.11e-05	9.41e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.8e-06	8.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.62e-06	8.15e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.59e-06	8.13e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.44e-06	8e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.77e-06	7.44e-05	CbGpPWpGaD
